Search research articles
Contact Us
Filters
Showing results (201-210 of 668) with videos related to
Page
of 67
Sort By:
Current Drug Metabolism
|
November 7, 2014
Measurement of anti-TNF agents and anti-drug antibodies serum levels in patients with inflammatory bowel disease
Iván Guerra, María Chaparro, Fernando Bermejo, et al.
The Cochrane Database of Systematic Reviews
|
October 14, 2014
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Mercedes Vergara, Cathy Bennett, Xavier Calvet, et al.
Drugs & Aging
|
February 10, 2024
Helicobacter pylori Eradication Treatment in Older Patients
Paulius Jonaitis, Juozas Kupcinskas, Javier P Gisbert, et al.
Digestive Diseases and Sciences
|
March 26, 2002
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review
Javier P Gisbert, Fernando Gomollón, José Maté, et al.
Helicobacter
|
May 12, 2007
13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding
Javier P Gisbert, Carlos Esteban, Isabel Jimenez, et al.
Helicobacter
|
May 26, 2004
The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice
Javier P Gisbert, Xavier Badía, Montserrat Roset, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation
A Montalban-Arques, M Chaparro, Javier P Gisbert, et al.
Gastroenterologia Y Hepatologia
|
May 22, 2009
[Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease]
José Ignacio Fortea Ormaechea, Javier P Gisbert, Ignacio Marín-Jiménez
Current Drug Metabolism
|
April 13, 2012
The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/- pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments
Dolores Serrano, Susana Torrado, Santiago Torrado-Santiago, et al.
Current Drug Metabolism
|
April 13, 2012
Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy
Teresa Cabaleiro, Manuel Roman, Javier P Gisbert, et al.
Page
of 67
Search research articles
Search
Showing results (201-210 of 668) with videos related to
Sort By:
Page
of 67
Current Drug Metabolism
|
November 7, 2014
Measurement of anti-TNF agents and anti-drug antibodies serum levels in patients with inflammatory bowel disease
Iván Guerra, María Chaparro, Fernando Bermejo, et al.
The Cochrane Database of Systematic Reviews
|
October 14, 2014
Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Mercedes Vergara, Cathy Bennett, Xavier Calvet, et al.
Drugs & Aging
|
February 10, 2024
Helicobacter pylori Eradication Treatment in Older Patients
Paulius Jonaitis, Juozas Kupcinskas, Javier P Gisbert, et al.
Digestive Diseases and Sciences
|
March 26, 2002
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review
Javier P Gisbert, Fernando Gomollón, José Maté, et al.
Helicobacter
|
May 12, 2007
13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding
Javier P Gisbert, Carlos Esteban, Isabel Jimenez, et al.
Helicobacter
|
May 26, 2004
The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice
Javier P Gisbert, Xavier Badía, Montserrat Roset, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation
A Montalban-Arques, M Chaparro, Javier P Gisbert, et al.
Gastroenterologia Y Hepatologia
|
May 22, 2009
[Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease]
José Ignacio Fortea Ormaechea, Javier P Gisbert, Ignacio Marín-Jiménez
Current Drug Metabolism
|
April 13, 2012
The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/- pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments
Dolores Serrano, Susana Torrado, Santiago Torrado-Santiago, et al.
Current Drug Metabolism
|
April 13, 2012
Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy
Teresa Cabaleiro, Manuel Roman, Javier P Gisbert, et al.
Page
of 67